Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001683168-17-000570
Filing Date
2017-03-15
Accepted
2017-03-15 12:51:26
Documents
5
Period of Report
2016-08-31

Document Format Files

Seq Description Document Type Size
1 10-K/A cannabics_10ka-083116.htm 10-K/A 539870
2 CERTIFICATION cannabics_10ka-ex3101.htm EX-31.1 11707
3 CERTIFICATION cannabics_10ka-ex3102.htm EX-31.2 11629
4 CERTIFICATION cannabics_10ka-ex3201.htm EX-32.1 4388
5 CERTIFICATION cannabics_10ka-ex3202.htm EX-32.2 4531
  Complete submission text file 0001683168-17-000570.txt   573357
Mailing Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 877-424-2429
Cannabics Pharmaceuticals Inc. (Filer) CIK: 0001343009 (see all company filings)

EIN.: 203373669 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-52403 | Film No.: 17690633
SIC: 2834 Pharmaceutical Preparations